Amneal Sale Purchase Of Stock from 2010 to 2025

AMRX Stock  USD 8.43  0.07  0.82%   
Amneal Pharmaceuticals, Sale Purchase Of Stock yearly trend continues to be fairly stable with very little volatility. Sale Purchase Of Stock is likely to outpace its year average in 2025. During the period from 2010 to 2025, Amneal Pharmaceuticals, Sale Purchase Of Stock regression line of annual values had r-squared of  0.04 and arithmetic mean of  5,526,038. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2016-12-31
Previous Quarter
-159 K
Current Value
-194 K
Quarterly Volatility
29 M
 
Covid
Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 154.9 M, Interest Expense of 254.3 M or Selling General Administrative of 281.2 M, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.096 or PTB Ratio of 50.74. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of Amneal Pharmaceuticals, Correlation against competitors.

Latest Amneal Pharmaceuticals,'s Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of Amneal Pharmaceuticals, Class over the last few years. It is Amneal Pharmaceuticals,'s Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amneal Pharmaceuticals,'s overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Pretty Stable
   Sale Purchase Of Stock   
       Timeline  

Amneal Sale Purchase Of Stock Regression Statistics

Arithmetic Mean5,526,038
Geometric Mean852,636
Coefficient Of Variation459.01
Mean Deviation12,247,365
Median40,000
Standard Deviation25,365,295
Sample Variance643.4T
Range107.4M
R-Value(0.19)
Mean Square Error665.1T
R-Squared0.04
Significance0.49
Slope(1,000,342)
Total Sum of Squares9651T

Amneal Sale Purchase Of Stock History

2025-2 M
2024-2.1 M
2023-2.4 M
2022-3.6 M
2021-2.7 M
2020-863 K
2019-926 K

About Amneal Pharmaceuticals, Financial Statements

Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of Stock-2.1 M-2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.